High-impact drugs such as topicals and combo packs often see low utilization, but carry exponentially higher costs. While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for potential benefits to injured workers, as they may provide relief that traditional therapies cannot. (Credit: Kenishirotie/Stock.adobe.com)

When we talk about addressing pharmacy issues in workers' compensation programs, opioid concerns often appear at the top of the agenda, and while opioid management remains an important focus, it is not the only pharmacy trend we must watch closely.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Coverage & Policy Issues
Workers' Comp